Dollar Store Doldrums, and Pot Stocks Light Up for a Second Straight Day 8/31/23
Aug 31, 2023
auto_awesome
George Archos, CEO of cannabis producer/retailer Verano, talks about the recent recommendation for marijuana legalization. Dollar General's poor financial performance and stock decline is also discussed, along with concerns about an upcoming recession and market analysis of Broadcom's earnings.
Dollar General's poor performance suggests a potential slowdown in consumer spending.
The Department of Health's recommendation to reassign cannabis to a less restrictive drug category could significantly benefit the industry.
Lulu Lemon reported strong earnings and is expected to continue its positive momentum in the third quarter.
Deep dives
Lulu Lemon Beats Expectations
Lulu Lemon reported a beat on the top and bottom lines, with revenue growth in North America and international markets. The company's forecast for the third quarter was above expectations, and it delivered strong operating and gross margins. While comparable sales growth slightly missed estimates, Lulu Lemon's strong momentum is expected to continue into the third quarter.
Dell Reports Q2 Earnings
Dell reported a beat on the top and bottom lines, exceeding expectations for revenue and profit. Gross margin and operating margin also beat estimates. The company's forecast for the third quarter was above expectations, and it experienced growth in both North America and international markets. Shares of Dell were up by approximately 8% after the earnings report.
Chewy Shares Drop After Earnings Report
Chewy reported an unexpected loss for the quarter, leading to a significant drop in shares. Revenue growth has also slowed down, raising concerns about the company's performance. However, options activity suggests that some traders are betting on a bounce, with short-dated call buying being observed.
Taylor Swift's Concert Documentary Coming to Theaters
Taylor Swift's record-breaking 'Evermore' tour will be available as a concert documentary in theaters. The film will be priced at $19.89 per ticket, and all major theater chains are expected to screen it. This move is expected to boost ticket sales and provide the movie industry with a much-needed fall boost. The concert documentary is set to release on October 13th.
US Officials Recommend Cannabis Rescheduling
US health officials have recommended that cannabis be reassigned to the less restrictive Schedule III drug category from its current Schedule I category. This news could have a significant impact on the cannabis industry and boost revenues and profits for companies like Verano Holdings. The company expects its bottom line to increase by over $100 million if the recommendation is implemented, particularly due to tax structure changes. This could provide a much-needed boost to the box office, which has been struggling during the pandemic.
Shares of Dollar General dropped to three-year lows after slashing sales and earnings guidance. So does this sector tell the true tail of the consumer? Plus marijuana stocks lit up again today as the Department of Health’s recommendation yesterday seemed to raise hopes for legalization. We talk to George Archos, CEO of cannabis producer/retailer Verano, to find out what it means for the industry.